Market Overview

Analysts Digesting News of Salesforce, ExactTarget Deal, Consider Implications for Marketo

Share:
Related CRM
Salesforce Refusing To Give Back Monster Gains: A Technical Look
Salesforce Soaring Following Earnings; Wall Street Reacts
Salesforce Becomes Fastest Enterprise Software Company To Reach $5 Billion (Seeking Alpha)
Related ET
Geron Gains As FDA Lifts Partial Hold On Imetelstat Study - Analyst Blog
Geron Plunges on FDA Clinical Hold - Analyst Blog

As traders in shares of Salesforce.com (NYSE: CRM) and ExactTarget (NYSE: ET) are responding to news of a $33.75/share deal for the former to purchase the latter Tuesday afternoon, analysts in the sector are also responding to the takeover. In addition to comments on Salesforce and ExactTarget, several analysts are also discussing the possible impacts on peers like Marketo (NASDAQ: MKTO).

Piper Jaffray analyst Mark Murphy believes the $2.5 billion deal presents potential to transform the fragmented e-mail marketing segment into a “big opportunity” for Salesforce.com. On the other side of the trade, Roth Capital analyst Nathan Schneiderman suggested the deal may cause “medium-term problems” for Marketo.

Schneiderman pointed out Marketo currently receives 90 percent of its sales from the customer base of Salesforce.com. Without long-term written contract with Salesforce.com, ExactTarget presents a direct threat to Marketo's revenue intake.

Analyst Kirk Materne from Evercore said the ExactTarget acquisition may, over the long term, put Salesforce.com on top of the emerging cloud-based marketing sector. He argued skeptics on the deal are likely to focus on the price and organic growth over the next few years, but assured strategic rationale is likely to outweigh these concerns over the long term.

Shares of Salesforce.com last traded down 3.6 percent, shares of ExactTarget are up more than 52 percent, and shares of Marketo are down nearly 8 percent. Shares of another peep in the sector, Responsys (NASDAQ: MKTG), are up nearly 6 percent at last check.

Latest Ratings for CRM

DateFirmActionFromTo
Feb 2015NomuraMaintainsBuy
Feb 2015Stifel NicolausMaintainsBuy
Feb 2015JefferiesMaintainsUnderperform

View More Analyst Ratings for CRM
View the Latest Analyst Ratings

Posted-In: Analyst Color News M&A Analyst Ratings

 

Related Articles (CRM + ET)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→